老九品茶

A personalised medicine specialist has raised 拢50 million in Series B funding. Headquartered at the Chesterford Research Park near Cambridge, Microbiotica has developed technology which uses the body鈥檚 trillions of resident bacteria – known as the microbiome – to discover and develop therapeutic medicines and biomarkers for a range of disorders and diseases.聽 The company鈥檚 … Continue reading 拢50m to power personalised medicine specialist